Home Life Sciences Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
Article Open Access

Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image

  • Shaofeng Zhang , Danqing Li and Xia Han EMAIL logo
Published/Copyright: September 30, 2023

Abstract

Lung cancer is the cancer with the highest mortality rate and the highest incidence in the world at this stage. Among them, non-small lung cancer is the most common type of lung cancer, and most small cancers have disappeared, which is the optimal time for surgery at the time of diagnosis. To explore and systematically evaluate the clinical efficacy of CYP1B1 gene polymorphism in the treatment of epidermal growth factor receptor (EGFR) Mutant non-small cell lung cancer, this article proposes the principles of lung cancer screening based on CYP1B1 gene polymorphism and polarization imaging and explores the diagnosis and treatment of non-EGFR mutant lung cancer. Based on a large number of medical image data, imageomics can directly reflect the correlation between tumor molecular phenotype and image characteristics by deeply mining some imaging features of the image, which has important value in the early diagnosis of disease, the formulation of personalized treatment plan, and efficacy evaluation and prognosis prediction. A total of 141 NSCLC patients with sensitive EGFR mutation were included in this study, including 101 patients with EGFR single-gene mutation and 40 patients with EGFR multigene mutation coexisting mutation. Both groups of patients were female, aged ≥60 years, no smoking history, no family history of leukemia, adenocarcinoma, lung cancer, stage IV, lymph node metastasis, living, far from metastasis, and ECOG score of 0–2. This study examined the relative number of gene expression and PFS in EGFR multigene co-existing mutations. When the number of mixed genes is 1, 2, and higher, the PFS is 9 months, 8 months, and 6 months, respectively. The PFS time of this group of patients gradually shortened. Therefore, this study examined the benefit of polygenic mutation in estimation by comparing the clinical characteristics of patients with EGFR single-gene mutation and polygenic mutation, to provide measurement of EGFR-TKI and to provide suggestions for future drug selection.

1 Introduction

Lung cancer is the malignant tumor with the highest incidence rate and mortality in the world. Non-small cell lung cancer (NSCLC) accounts for 75–80% of primary lung cancer. Due to the lack of a comprehensive early screening and diagnosis system, more than half of NSCLC patients have reached advanced stages when detected, with a 5-year survival rate of less than 30%. In the past 10years, the detection of Epidermal growth factor receptor (EGFR) mutation and the application of Epidermal growth factor receptor Tyrosine kinase inhibitors (EGFR-TKIs) have opened a new era in the treatment of advanced NSCLC. EGFR is a Tyrosine kinase receptor (also known as ErbB-1 or HER1), which is a member of the Epidermal growth factor receptor (HER) family.

The human EGFR gene is located in the short arm 7P12-14 region of Chromosome 7 and consists of 28 Exon. In NSCLC patients, EGFR mutations are mainly concentrated in 18–21 Exon. EGFR gene mutations are mainly dominant in Asian, female, non-smoking, and adenocarcinoma patients. The most common types of mutations are 19 Exon deletion mutations (Del19) and 21 Exon L858R Point mutations, which account for 90% of all EGFR mutation populations. Among advanced NSCLC patients in China, about 50% of them have different types of EGFR gene changes. Many large clinical studies have shown that in advanced NSCLC with EGFR mutant, especially NSCLC patients with 19 Exon deletion or 21 Exon L858R mutant, the progression-free survival (PFS) and overall survival (OS) of the first-generation EGFR-TKIs as the first-line treatment plan are significantly longer than those of the traditional first-line chemotherapy plan based on platinum (carboplatin, cisplatin, Nedaplatin, etc.). However, almost all patients with EGFR-sensitive Mutant advanced NSCLC inevitably develop secondary drug resistance after starting EGFR-TKIs Targeted therapy for 8–24 months, and then disease progression occurs. However, there are also some patients who, despite the presence of EGFR-sensitive mutations, still experience disease progression within the short term (usually within 3 months) of starting treatment with EGFR-TKIs, indicating the presence of primary EGFR-TKIs resistance. At present, the mechanism of acquired drug resistance in first-generation EGFR-TKIs has not been fully elucidated. Current research shows that approximately 50% of the secondary resistance of first-generation EGFR-TKIs is caused by EGFR Exon 20 T790M secondary mutations. Other types of secondary drug resistance mutations include L747S, D761Y, and T854A. Possible mechanisms lead to primary resistance in first-generation EGFR-TKIs include PIK3CA mutations, MET amplification, BIM polymorphism, changes in the PIK3CA-AKT-mTOR signaling pathway, and the transformation from NSCLC to small cell lung cancer.

The meaning of imageomics is to extract high-throughput features from a large number of medical images and carry out feature mining, use statistics and machine learning methods to screen the most valuable imageomics features, and correlate them with other clinical data. It is widely used in a variety of tumor lesions. The research scope includes the genetic phenotype of tumor lesions, tumor grading and staging, efficacy evaluation, and prognosis prediction. The imaging texture features can not only reflect the internal heterogeneity of the tumor but also have some correlation with the biological characteristics of the tumor such as hypoxia, glucose metabolism, and angiogenesis. At present, there are many studies on tumor lesions such as lung, colon cancer, and prostate cancer in imageomics, while the research of head and neck tumors is mainly used to evaluate the prognosis and the changes in biological characteristics and functional information of the lesions after radiotherapy and chemotherapy.

In recent years, cancer has gradually become the disease with the highest mortality rate worldwide. Meanwhile, according to the latest cancer data report released in 2021, there are about 790,000 cases of lung cancer in China every year, and about 631,000 of them die. According to NCCD’s in-depth research on pathogenesis, the oncogenic activity of various oncogenes, including oncogenes, has been linked to the treatment of lung cancer may be difficult due to genetic polymorphisms. In addition, polymorphism of the CYP1B1 gene can be used to study pulmonary disease. Therefore, this article focuses on the study and diagnosis of EGFR, as shown in Figure 1, cell screening, and polarization imaging based on the CYP1B1 gene polymorphism.

Figure 1 
               Gene polymorphisms in EGFR mutations in non-small cell lung cancer.
Figure 1

Gene polymorphisms in EGFR mutations in non-small cell lung cancer.

2 Literature review

In recent years, the TP53 gene has been a hot topic of widespread concern among scholars. At present, different classification standards of TP53 gene mutation have been derived according to the mutation site, mutation nature, and biological effects caused by the mutation. For example, according to the type of mutation, TP53 gene mutations can be divided into Missense mutation and non-Missense mutation; Missense mutation refers to the change of amino acid type and sequence of P53 protein polypeptide chain after base substitution of the codon encoding some amino acid at the mutation site. Except for Missense mutation, all TP53 mutations that can cause changes in the amino acid sequence of P53 protein are collectively referred to as non-Missense mutation (Nonsense mutation, deletions, in frame insertions, cuts, frameshift mutations, etc.). As an emerging field, imageomics is expected to more and more influence the clinical practice of various tumor treatments, optimize the end-to-end diagnosis, treatment, and follow-up chain, and may completely change the traditional classical methods based on macroscopic and microscopic analysis of tumor characteristics. Although small cell carcinoma is usually treated with surgery, 90% of patients will delay surgery once diagnosed, and only about 20% can be cured by surgery. Nearly half of the patients developed local or distant metastases shortly after surgery. After platinum-based chemotherapy is not completed, the survival time is only 5–7 months, and the level of liver cancer treatment is stagnant [1].

Latreille and others designed a mobile phone polarized light microscope and used mobile phone imaging to observe the lesion position of malaria cells in tissues [2]. Iizuka and others took polarized images of animal oocytes at different stages of mitosis and polarized fluorescence imaging of brain tissue by polarizing microscope LCPolScope and analyzed and studied them [3]. Nishio and others used the imaging system to measure the sections of rat liver tissue, obtained the Stokes vector parameters of healthy part and hematoma part, and obtained the Mueller matrix through this vector, so as to quantitatively analyze the polarization characteristic data of rat liver tissue sections [4]. Dammeijer and others used Mueller to analyze and study the anisotropic structure of skeletal muscle [5]. Wakuda and others established different model structures, simulated these structures, obtained Mueller matrix parameters under these models, analyzed them in detail, and applied the analysis results to the study of various heterosexual structures such as skeletal muscle [6]. Wang and others used the polarization method to analyze the cancerous colon, thus proving that the polarization characteristics of cancerous tissue will change compared with normal cancerous tissue [7]. Xu and others studied the polarization characteristics and also quantitatively analyzed it by using gray-level co-occurrence matrix [8]. Lu and others found that the element asymmetry of the birefringent object in the Mueller matrix measured by double-layer sample is higher than that of single-layer sample by using the polarized light imaging method [9].

We have a further understanding of the mechanisms of abnormal proliferation, infiltration, and metastasis of malignant tumor cells at the molecular and cellular levels. The emergence of tumor molecular lead to drugs has brought new hope to patients with advanced lung cancer. Different from traditional cytotoxic drugs, molecular targeted therapeutic drugs take cell receptors, genes, regulatory molecules, and other signal transduction as the boot point, specifically act on these specific sites of tumor cells, and highly selectively kill tumor cells. It is a new drug with high toxicity and side effects and has a very good prospect in the field of tumor treatment [10].

3 NSCLC formation process and a representation of polarized light

3.1 Review of TCM and argon-helium knife cryotherapy for NSCLC

Although image observation has been applied to many diseases, lung cancer is by far the most widely studied and characteristic malignant tumor through image observation. The research of image observation on lung cancer mainly includes the following aspects: First, it is used for cancer detection, contour and feature description. Because some lung nodules may be small and similar to other structures in the lung (such as blood vessels) or benign processes (such as focal organizing pneumonia), CT-based lung cancer screening has a high false positive rate. Because malignant lung lesions have different image structure features from benign lesions on CT, the image features based on CT have high accuracy in differentiating benign and malignant lesions. Surgery, radiotherapy, and chemotherapy are still the three pillars in the treatment of NSCLC. Molecular targeted therapy and traditional Chinese medicine are also important means in the treatment of NSCLC. About 80–90% of patients with lung cancer can be clearly diagnosed by chest X-ray, CT, bronchoscopy, percutaneous needle aspiration biopsy, positron emission tomography (PET/CT) and other clinical examination methods, but most patients have no obvious symptoms in the early stage, 70–90% have lymph node metastasis and hematostatic spread when they visit the doctor. Even in the lung, brain, bone, liver, adrenal, subcutaneous and other distant metastasis, in the middle and late stage, lost the opportunity of surgery, also missed the best treatment opportunity, can only choose radiotherapy and chemotherapy, Traditional Chinese medicine or targeted therapy. The emergence of new technologies and new treatment ideas provides treatment opportunities for patients in the middle and late stages, which solves many clinical problems to a certain extent and even challenges traditional treatment methods. The status of surgery, radiotherapy and chemotherapy in the comprehensive treatment of NSCLC has been severely challenged, especially for patients with advanced lung cancer, the status of radiotherapy and chemotherapy has begun to shake. Minimally invasive techniques such as argon-helium knife cryoablation and radiofrequency ablation have been able to provide some benefits for patients with advanced lung cancer, offering the opportunity for local “excision,” even in some early patients, as good as surgical excision. Biotargeted therapies such as irressa and tarceva have an absolute advantage in the efficacy of certain NSCLC patients and have replaced radiotherapy and chemotherapy as first-line treatments. However, the effectiveness of modern medical treatments is still limited, with more than 80% of all lung cancer patients dying within a year. According to the 2012 China Cancer Registration Annual Report, lung cancer still occupies the first place in the incidence of malignant tumors in China, with the incidence reaching 53.57/100,000 and the mortality reaching 45.57/100,000. Lung cancer still occupies the first place in the mortality rate of malignant tumors, and the incidence of smoking males over 45 years old is the highest. The ratio of annual deaths to new cases is as high as 0.86, indicating that the cure rate is extremely low. It is still increasing year by year due to food hygiene, smoking, automobile and industrial development of air pollution and other reasons.

3.2 Understanding of lung cancer in traditional literature

There is no specific cancer to record lung cancer in traditional Chinese medicine literature, but the earliest record of tumor can be traced back to the Shang Dynasty, and the word “tumor” was recorded on the oracle bones in Yin Dynasty dynasty. “Spirit pivot low stab section really evil” also expounds the “tumor”, think the etiology and pathogenesis of “tumor” is “there has been a knot, qi’s, leave of the body fluid, pathogens, in the condensation, with very easily, even to live forever tumor, by hand press the”, which describes the tumor palpate the texture “nut”, observe its onset is “” day in, and sums up the etiology is not pure. Jin low ge hong’s “elbow backup nasty party” documented malignant tumor of the typical clinical manifestations: “governance died suddenly and violently, belly with objects such as stone, pain like a thorn, crow cried day and night, not conquer one hundred death,” and describes in detail the occurrence, development and prognosis, and believe that “every disease of the firm, to grow more, if you have died, and prison from refractory also, womb disease have a knot, and diet, turn win thin”. Especially the scholar-officials also think its “more” to emerging, conforms to the modern understanding of malignant tumor is a chronic disease, tumor and think it’s difficult to be found early, once found that most tumor has been heavier load and difficult to treat, and against the pain caused by cancer patients, tumor appear to the late development state of cachexia has also done a detailed observation records. The author made a preliminary summary of the clinical transmission and treatment of malignant tumors in General Record of Shengji. Gall Gate in Song Dynasty: “Tumor is just, stay and do not go.

3.3 TCM etiology and pathogenesis of lung cancer

The tumor phenotype should be associated with the tumor genotype. Image observation involves qualitative and quantitative phenotypes to identify specific genetic map characteristics. With the introduction of genome map in clinical practice, cancer treatment decisions are increasingly based not only on the clinical characteristics of patients and tumor morphology, but also on individual mutation map. Due to the genetic complexity and heterogeneity of lung cancer, it is suggested that NSCLC with some carcinogenic driving factors can become the target of other indications or clinically developed drugs, which has potential clinical therapeutic significance. There is no direct description of the etiology and pathogenesis of lung cancer in the ancient literature, but from the records of various lung diseases, we can see the ancient philosophers’ elaboration on the etiology, pathogenesis and treatment of lung cancer. “Plain ask – Stabbing method theory” in the “positive gas storage, evil cannot dry, avoid its poison”, how can evil poison play a role in hurting the human body? If the individual vital qi is strong, it will naturally resist evil poison, and when the body vital qi is weak, then “four eight winds to the guest in the meridian, for the six diseases” (“Lingshu – Nine needle treatise”). At the same time, neijing also points out that “internal injury is caused by sorrow and anger, which accumulates into Yi”, and holds that abnormal emotion can also cause internal injury, which leads to lack of positive qi, which is also one of the causes of accumulation. As early as in China’s Qing Dynasty, there are doctors on smoking carcinogenesis explanation, Qing Gu Songyuan thought that “smoke is hot chief, very can hurt Yin, and six sex and seven emotions can fire, phlegm and stasis days long can heat, heat yu days long, into heat poison, heat poison fetor lung, blocking airway, lung qi gongyu, brew cancer poison.” At the same time, his understanding of lung cancer is also focused on heat, heat, that the pathogenesis of the six sexual and seven emotions of heat into a long day of heat poison – heat poison to prevent lung a brew of cancer. This is, to some extent, consistent with modern medicine. Ancient books “miscellaneous diseases source stream Xi Candle” recorded “evil accumulation in the chest, blocked airway, gas can not pass, for. Phlegm. For blood, evil is muscle, evil, both are not made, hence forming shape and had a”, can generally reflect the etiology and pathogenesis of lung cancer: when there is pay for good and evil, evil poison knot in pathogens and vital qi is deficient cannot resist evil, cause lung qi activity, xuan drop loss, TanNing and qi stagnation, collaterals and blood stasis resistance, gradually forming block, eventually sent for lung. For the treatment of lung cancer, Li Zhongzi, a doctor in Ming Dynasty, also gave quite clear guidance in his Medical School Must-Read: “In the beginning, diseases and evil spirits are just beginning to rise, while the positive spirit is still strong and the evil spirit is still shallow. In, the disease gradually, the evil spirit is deeper, the positive spirit is weaker, any and attack and fill; At the end, the disease lasts for a long time, the evil spirit infers, the positive qi dissipates, and then the patient is compensated. “It can be said that up to now, this is still the treatment strategy adopted by most TCM oncologists and even western doctors.

The interaction between host and environmental factors can cause chromosome deletion and inactivation of tumor suppressor genes, and this research is currently in the preliminary stage of research. Common types of lung cancer include adenocarcinoma, squamous cell carcinoma, large cell undifferentiated carcinoma, and small cell lung cancer. Currently, adenocarcinoma is the most common histopathological type, accounting for 30–40% of lung cancer; Squamous cell carcinoma was the most common in the past, but has now been replaced by adenocarcinoma. Large cell undifferentiated carcinoma belongs to the type of large cell tissue, but it is difficult to classify histologically as squamous cell carcinoma or adenocarcinoma. Small cell lung cancer originates from the neuroendocrine cell line, with a faster growth rate, strong invasiveness, and poor prognosis. In the current diagnosis and treatment strategies for lung cancer, it is not important to distinguish between squamous cell carcinoma, adenocarcinoma, or large cell carcinoma. The important difference lies in whether it is small cell lung cancer or NSCLC. As lung cancer tissue continues to grow, and due to differences in tumor growth location and biological characteristics, various clinical symptoms and outcomes can occur:

  1. Space occupying effect. The tumor tissue may cause damage to the body through compression of normal tissue structure, such as Venae cavae syndrome or Hoarse voice caused by compression of Recurrent laryngeal nerve.

  2. Invading normal tissues directly leads to tissue damage. For example, the erosion of bones and blood vessels by tumors can cause pain and bleeding; Invasion of pleura and pericardium can cause Pleural effusion or pericardial effusion respectively.

  3. Blocking the airway can cause obstructive pneumonia, cough, and respiratory distress.

  4. The production of bioactive substances leads to paraneoplastic syndrome, such as Vasopressin secretion disorder syndrome (SIADH), hypertrophic pulmonary osteoarthropathy, and hypercalcemia. Lung cancer can also cause consumptive changes in the body, leading to weight loss and fatigue, and its pathogenesis is still unclear.

  5. Extrapulmonary metastasis, involving distant organs. The liver, adrenal gland, brain, and bone are common sites of extrapulmonary metastasis in lung cancer.

3.4 Representation of polarized light

Polarized light, an optical term. Light is an electromagnetic wave, and electromagnetic waves are transverse waves. The plane formed by the direction of vibration and the direction of light wave progression is called the vibration surface, and the vibration surface of light is limited to a fixed direction, called plane polarized light or line polarized light.

The polarization phenomenon of light can be detected using experimental devices, with P1 and P2 being two identical polarizers. Observing natural light (such as light or sunlight) directly through a polarizer p1, although the light passing through the polarizer becomes polarized light, it cannot be detected by the human eye due to its inability to distinguish polarized light. If we fix the orientation of polarizer P1 and slowly rotate polarizer P2, we can observe periodic changes in the intensity of transmitted light as P2 rotates, and the luminous intensity will repeatedly decrease from maximum to darkest every 90° rotation; Continuing to rotate P2 will gradually increase the light intensity from close to zero to its maximum. From this, it can be seen that the transmitted light through P1 has different properties from the original incident light, indicating that the vibration of the transmitted light through P1 does not have symmetry in the direction of propagation. After passing through a polarizer, natural light changes into light with a certain vibration direction. This is because there is a characteristic direction in the polarizer, called polarization direction. The polarizer only allows vibrations parallel to the polarization direction to pass through, while filtering out light that vibrates perpendicular to that direction. Through the transmission of light through a polarizer, its vibration is limited to a certain direction of vibration. We call the first polarizer P1 the “polarizer”. Its function is to convert natural light into polarized light, but the human eye cannot distinguish polarized light. It is necessary to rely on the second polarizer P2 for inspection. Rotate P2, when its polarization direction is parallel to the polarization plane of polarized light, the polarized light can pass smoothly, and there is brighter light behind P2. When the polarization direction of P2 is perpendicular to the polarization plane of polarized light, polarized light cannot pass through and darkens behind P2. The second polarizer helps us identify polarized light, hence it is also known as a “polarizer”.

3.4.1 Jones vector

Typically, polarized light is elliptically polarized light. If the light is presented in the z-axis direction, the projection of a beam of elliptically polarized light on the coordinate axis of the XY plane is shown in formulas (1) and (2).

(1) E x = E 0 x e i ( ω t k z + ϕ 0 x ) = E 0 x e i ω t e i ϕ 0 x ,

(2) E y = E 0 y e i ( ω t k z + ϕ 0 y ) = E 0 y e i ω t e i ϕ 0 y .

The common factor is removed, and the projection expression is expressed by complex number and amplitude, which is shown in formulas (3) and (4).

(3) E x = E 0 x e i ϕ 0 x ,

(4) E y = E 0 y e i ϕ 0 y .

American physicists have found that the above formula can be expressed more efficiently by introducing a column matrix composed of mutually orthogonal components. This expression is called Jones vector. Its expression is shown in formula (5).

(5) E x E y = E 0 x e i ϕ 0 x E 0 y e i ϕ 0 y .

Therefore, the intensity of polarized light can be expressed by formula 6.

(6) I = E x 2 + E y 2 = E 0 x 2 + E 0 y 2 .

3.4.2 Stokes vector

The Stokes vector method uses four metrics to determine the light intensity in different directions and states, and the resulting data is shown in equation (7).

(7) S = I Q M V = F x 2 + F y 2 E x 2 E y 2 2 E n E x cos σ 2 E x E y sin σ = N x + N y N x N y Y + 45 Y 45 B R B L .

Table 1 provides the Stokes vectors for different graphs with different polarization states.

Table 1

Several special Stokes vector parameters

Special Stokes vector M Q U N
Level 2 1 1 0
Vertical line 2 6 0 0
45° plate polarization 3 0 2 1
Right circular polarization 8 0 4 2

According to Stokes not, some polarizations are not available, such the expression for the degree of polarization is shown in equation (8).

(8) P = Q 2 + U 2 + I 2 I .

3.4.3 Mueller matrix

Since the Stokes vector can be a feature, the incident problem and the light emitted after entering the polarizer can be represented by the Stokes vector. The relationship between light events, light output, and past problems is shown in formula (9)

(9) s = m s .

Formula (9) is expressed in the form of matrix, and the result is shown in formula (10).

(10) S 1 S 2 S 3 S 4 = N y 12 n 13 n 14 n n 22 n 23 n 24 n 31 n 32 n 33 n 34 m n 41 n 42 n 43 n 44 S 1 S 2 Y 3 Y 4 .

Nueller matrix is shown in formula (11).

(11) M = m 11 n 12 n 13 n 14 m 21 n 22 n 23 n 24 m 31 n 32 n 33 n 34 m 41 n 42 n 43 n 44 .

There are many parameters to describe the polarization characteristics by Mueller matrix, among which the degree of polarization and polarization difference are the most commonly used. The expression of degree of polarization is shown in formula (12).

(12) P = I p I t = I max I min I max + I min .

Degree of polarization (DOP) parameters and polarization difference (DP) parameters are an important standard to characterize the polarization characteristics of samples [11]. These parameters were first used in polarization imaging methods and applied to clinical diagnosis [12]. Because the optical imaging method has some limitations in detecting tissue, and the polarization imaging method can improve the imaging contrast of biological tissue, it is often used with skin tissue detection. Degree of polarization and polarization difference can characterize the polarization characteristics of substances [13]. The expression of degree of polarization obtained by Nueller matrix is shown in formula (13).

(13) D O P = m 21 + m 22 m 11 + m 12 .

The Mueller matrix expression of polarization difference is shown in formula (14).

(14) D P = m 21 + m 22 .

3.4.4 Gray associative matrix

So it is generally effective to use pattern texture measurement. In general, the texture formed recursively in the spatial position of the gray value distribution in the graph is determined as the texture, that is, the texture, and the texture has intertwined features, that is, there may be some gray interactions. between some two pixels [14]. The grayscale phase co-occurrence matrix is a statistical matrix that calculates the occurrence time of pairs of grayscale values that have the same grayscale value in a certain direction and another point at a distance [15]. The principle is shown in Figure 2.

Figure 2 
                     Principle of gray level co-occurrence matrix.
Figure 2

Principle of gray level co-occurrence matrix.

4 Experiment

Image observation can quantitatively analyze and fully mine the relationship between pixels and spatial distribution in the image, supplement the traditional morphological imaging features, and can be used as a useful imaging diagnostic tool for early prediction of EGFR gene mutations in patients with NSCLC. The heterogeneity of lung cancer is related to many factors, such as changes in growth factors and angiogenesis factors, mutations in related gene subtypes or changes in tumor microenvironment. The tumor morphology, internal density and other characteristics provided by the image can indirectly provide relevant information from the overall level for tumor heterogeneity analysis. The CT-based imageomics can help to improve the sensitivity and accuracy of differentiating benign and malignant lung lesions, non-invasive identify lung cancer of different pathological types, quantitatively predict the mutation status of lung cancer gene, and evaluate the heterogeneity of lung cancer to help clinical personalized treatment Predict and evaluate treatment response and prognosis of lung cancer patients. 141 patients were finally selected for inclusion and exclusion according to the criteria. Important data on these patients included gender, age, important site, disease type, treatment stage, lymph node metastasis, distant metastasis, smoking history, tumor, and family history of tumor (according to ECoG scoring criteria). EGFR mutant strains, coexisting genes, EGFR-TKI therapy, and post-treatment vaccines were documented and regularly followed [16].

Tissue or body fluids (blood, urine, pleural effusion, etc.) have EGFR altered by NGS detection Sensitivity, with or without other gene mutations; Receiving EGFR-TKI; Viruses can be detected according to RECIST version 1.1 and regularly checked in our hospital; Adults (age ≥18 years old) are generally in good condition [17].

Exclusion criteria: 1. Have serious organic diseases such as liver and kidney function and heart failure; 2. Complicated with other malignant tumors or serious infection; 3. Those who have taken EGFR-targeted drugs before advanced stage; 4. Failure to review regularly, incomplete treatment and review information, or loss of follow-up; 5. Taking targeted drugs combined with other treatment schemes that can significantly affect the prognosis; 6. Irregular medication or self-discontinuation of targeted drugs [18].

5 Clinical characteristics of patients with EGFR single gene mutation and multi gene coexisting mutation

5.1 Clinical features

The clinical characteristics of the two groups are as follows (Table 2). In the same point, both groups were female (single mutation group vs coexisting mutation group, 69.3% vs 67.5%); Age ≥60 years old (single mutation group vs coexisting mutation group, 63.4% vs 60.0%); No smoking history (single mutation group vs coexisting mutation group, 74.3% vs 82.5%); No family history of tumor (single mutation group vs coexisting mutation group, 85.1% vs 72.5%); Adenocarcinoma (single mutation group vs coexisting mutation group, 98% vs 97.5%); right lung (single mutation group vs coexisting mutation group, 61.4% vs 57.5%); Stage IV (single mutation group vs coexisting mutation group, 68.3% vs 70.0%); Lymph node metastasis (single mutation group vs coexisting mutation group, 57.4% vs 67.5%); Single site distant metastasis (single mutation group vs coexisting mutation group, 53.5% vs 40.0%); ECoG 0–2 points (single mutation group vs coexisting mutation group, 90.1% vs 87.5%) [19]; First generation EGFR-TKIs (including ektinib, gefitinib, and erlotinib) treatment (single mutation group vs coexisting mutation group, 96.1% vs 87.5%); No T790M mutation was common after treatment (single mutation group vs coexisting mutation group, 88.1% vs 85.0%) [20]. There were more exon 19 deletions in the EGFR single gene mutation group (single mutation group vs coexisting mutation group, 55.4% vs 40.0%); The EGFR polygenic mutation group had more mutations in exon 21 L858R (single mutation group vs coexisting mutation group, 40.6% vs 52.5%). As shown in Table 2.

Table 2

Clinical characteristics of EGFR single gene mutation group and EGFR multigene coexistence mutation group

EGFR multigene coexistence mutation EGFR single-gene mutation X 2 p
Gender Male 31 13 0.016 0.29
Female 70 27
Age >60 18 0.2369 3.69
<70 28
Smoking history Yes 26 0.269 4.21
No 30
clinical stages 32 12 1.236 8.36
69 15

5.2 Gene distribution of EGFR multigene coexisting mutation group

The gene distribution of 40 advanced NSCLC patients with EGFR multigene co-mutation is as follows (3). Exon 19 was removed in 16 cases, and exon 21 L858R was replaced in 21 cases. Other changes included 2 cases of exon 21 l861q and 1 case of exon 18 g719a. Coexisting gene mutations were higher at the exon 21 L858R transition (exon 19 versus exon 21, 40% versus 52.5%) [21]. Among all gene mutations, TP53 mutation is the highest. Of these, 20 patients switched to TP53, accounting for 50% of the change in this group, followed by BIM (10%) and PIK3CA (10%) mutations. In the gene transfer data of this study, 20 patients were associated with only 1 mutation, including 7 with TP53 mutation, 3 with BIM removal, 2 with ros1 alteration, and 2 with ALK altered 3 times. Amplification, 1 case of PIK3CA mutation and 1 case of HER2 amplification mutation. Another 20 patients were diagnosed with multiple genetic mutations, as shown in Figure 3.

Figure 3 
                  Distribution of coexisting gene mutations in patients with EGFR mutation-positive advanced NSCLC.
Figure 3

Distribution of coexisting gene mutations in patients with EGFR mutation-positive advanced NSCLC.

5.3 Relationship between EGFR coexisting gene mutations and the efficacy of EGFR-TKIs

The performance measures for the two patient groups in this study are shown in Table 3: CR was not achieved in either group. The ORR of EGFR gene mutation group and EGFR multigene co-mutation group were 31.7 and 45%, respectively.

Table 3

Comparison of curative effects

Efficacy evaluation EGFR single gene mutation EGFR polygenic coexistence mutation P
PD 6 (6.0%) 3 (6.0%) 2.000
PR 31 (32.3%) 21 (34.0%) 0.213
S D 54 (34.7%) 23 (45.0%) 0.258
ORR 21.9% 55% 0.257

5.4 Relationship between EGFR coexisting gene mutations and PFS after EGFR-TKIs treatment

Changes in EGFR polygenic mutations after EGFR group-mutated PFS and EGFR-TKI treatment are shown in Figure 4. The mean PFS for EGFR mutations was 12 months, and the mean PFS for the EGFR polygenic co-mutation group was 7 months. Univariate screening determined the patient’s age, sex, smoking history, tumor family history, disease, ECoG score, and type of EGFR change (only exon 19 was removed and L858R was identified). The results are shown in Table 4. Family history of leukemia and treatment level were found to be negative for PFS (P-values 0.019 and 0.014, respectively), with no differences in PFS with respect to age, sex, smoking history, lymph node metastasis, and ECoG score. Many tests include family history of the EGFR group, stage of treatment, and cancer. The results showed that the association of EGFR, that is, the combination of multiple gene mutations, was an independent effect on negative PFS (P = 1.017, HR = 2.705, 96%). CI: 1.101–3.641), see Table 5.

Figure 4 
                  PFS curve of EGFR single gene mutation group and EGFR multigene coexistence mutation group.
Figure 4

PFS curve of EGFR single gene mutation group and EGFR multigene coexistence mutation group.

Table 4

Univariate analysis of PFS after EGFR-TKIs treatment

Factor Frequency X 2 P
Gender Male 47 0.043 0.853
Female 89
Age <60 61 0.003 0.965
≥60 92
Smoking history Yes 34 0.021 0.972
No 104
Family history of tumor Yes 24 5.098 0.021
No 109
Table 5

Relationship between multiple factors and PFS by Cox regression analysis

95% CI
β Standard deviation Waldx2 P HR Lower limit Upper limit
EGFR grouping 0.456 0.213 5.674 0.019 1.431 1.232 2.478
Family history of tumor −0.386 0.295 2.871 0.142 0.570 0.246 1.109
Stages −0.32 0.254 1.68 0.198 0.612 0.655 1.466

5.5 Relationship between EGFR coexisting gene mutation and OS after EGFR-TKIs treatment

The OS after EGFR-TKI treatment in the EGFR single-gene mutation group and the EGFR multigene co-mutation group is shown in Figure 5. 26 mm vs 26 mm 26 mm 21 months), but there is no difference between the two groups (P = 0.284) in outcomes including patient age, sex, smoking history, family history, health status, ECOG score, and type of EGFR change (only two exon 19 variants and L858R were identified), as shown in Table 6. Treatment levels were found to be negative for OS (P = 0.017), age, sex, smoking history, family history of tumors, ECOG score, and EGFR changes. EGFR groups and treatment stages are included in various tests. EGFR group was not associated with OS (P = 1.04, HR = 1.615, and 96% CI: 1.122–2.552).

Figure 5 
                  OS curve of EGFR single gene mutation group and EGFR multigene coexistence mutation group.
Figure 5

OS curve of EGFR single gene mutation group and EGFR multigene coexistence mutation group.

Table 6

Univariate analysis of OS after EGFR-TKI treatment

Factor Frequency X 2 p
Gender Male 46 0.767 0.342
Female 89
Age <60 45 0.156 0.768
≥60 91
Clinical stages Phase III 45 5.378 0.019
Phase IV 98
Lymph node metastasis Yes 89 0.131 0.782
No 57

5.6 Relationship between the number of genes and PFS

This study examined the relative numbers of gene expression and PFS in a panel of EGFR polygenic coexisting mutations. The results are shown in Figure 6. When the number of mixed genes was 1, 2, and higher, the PFS was 9, 8, and 6 months, respectively. The PFS time was gradually shortened in this group.

Figure 6 
                  Relationship between the number of coexisting gene mutations and PFS.
Figure 6

Relationship between the number of coexisting gene mutations and PFS.

6 Discussion

Combining molecular biological characteristics with imaging characteristics is also the development trend of tumor diagnosis and treatment in the future. In recent years, the efficacy of chemotherapy has reached a bottleneck. The median OS is about 7–12 months, and the 2-year survival rate is only 10–11%.genomics and molecular detection technology, the control targets of gene processing have gradually increased, especially the discovery of EGFR-producing genes. EGFR is widely distributed, in fibroblasts and other cells, and plays an important role in cell proliferation and differentiation. The rate of change in NSCLC patients is approximately 19–50%. The most common variants are exon 30 deletions and exon 41L858R converters. Because EGFR-TKIs are unique and rare, and their therapeutic effects are superior to therapeutic drugs, they have become the first-line treatment for patients with EGFR-sensitive and sensitive NSCLC. Earlier studies thought the genes were cohesive, but in recent years, patients with multiple mutations have been identified. However, multigene co-mutation in NSCLC patients is very low, accounting for only 1–6%. Currently, implementation of the T790M variant EGFR-TKI-related expansion has been declared inappropriate; 18 patients were diagnosed with the T790M mutation and developed immunity after developing. However, the effects and correlations of polygenic mutations on the efficacy of EGFR-TKIs are still unclear, and some studies have been conducted. Of the 141 patients, 93.6% received first-generation EGFR-TKI therapy. Therefore, this study examined the benefit of polygenic mutation in estimation by comparing the clinical characteristics of patients with EGFR single-gene mutation and polygenic mutation. To provide measuring of EGFR-TKI, to provide suggestions for future drug selection.

7 Conclusion

This article presents the principle of lung cancer screening based on CYP1B1 gene polymorphism and polarization imaging and explores the diagnosis and treatment of non-EGFR mutant lung cancer. Based on a large number of medical imaging data, imaging omics directly reflects the correlation between tumor molecular phenotype and imaging features by deeply mining some imaging features and is of great value for early diagnosis, the formulation of personalized treatment plan, efficacy evaluation, and prognosis prediction. The clinical data of this study showed that the incidence of EGFR polygenic coexisting mutations in non-small tumors was about 8.7%, while the incidence of TP53, BIM, PIK3CA, and other factors such as age, gender, smoking history, disease and other factors was about 8.7%. Tumor family history, treatment level, lymph node metastasis, EGFR mutation type, and EGFR mutation immune score combined several EGFR groups, but both groups were mostly female, nonsmoking, ≥60 years old, and leukemia patients. The clinical characteristics of 299 patients with EGFR mutation and 21 patients with EGFR mutation were compared, and the difference was not significant. This study shows the relative amount of gene expression and PFS in coexisting mutations in EGFR. The results are shown in Figure 6. When the number of admixed genes was 1, 2, and higher, the PFS was 9, 8, and 6 months, respectively. The PFS time was gradually shorter in the patients in this group. Considering the reasons for the differences between studies, first, sample size; second, Guibert’s study focused on all lung cancer patients, and it can calculate the time it takes them to go through multiple changes. The study material for this study is based on EGFR-mutant NSCLC patients with or without other genetic mutations. The research potential of the two studies was different, so the results were different. In the future, with the further maturity of image observation, the diversification of research queues, the improvement of large samples and multi-center databases, and the update of machine learning algorithms, the above problems can be effectively solved. How to explore new targets and develop corresponding targeted drugs. At present, only a few molecular targets of lung cancer have been confirmed to be clinically significant, and corresponding targeted inhibitors have been approved for marketing. Another part of the targets and corresponding inhibitors are still in the clinical research stage, but more valuable drug targets have not yet been found. It is believed that in the future, with the promotion and application of high-throughput sequencing and the rapid development of molecular biology technology, as well as the in-depth discussion of clinical research and the invention of the mechanism of the occurrence and development of lung cancer, more unknown or immature targets will be gradually understood, and the corresponding research and development of targeted drugs and clinical applications will also make significant progress, and the Targeted therapy of lung cancer will inevitably move towards precision, individualization, and maturity, Thus, more and more patients will truly benefit from survival. Image observation will also have a broader application prospect in the molecular diagnosis and treatment of lung cancer.

  1. Funding information: The research was funded by the Xingtai Science and Technology Bureau (2021ZC129).

  2. Conflict of interest: Authors state no conflict of interest.

  3. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Lin M, Liang SZ, Wang XH, Liang YQ, Zhang MJ, Niu LZ, et al. Clinical efficacy of percutaneous cryoablation combined with allogenic nk cell immunotherapy for advanced non-small cell lung cancer. Immunol Res. 2017;65(4):880–7.10.1007/s12026-017-8927-xSearch in Google Scholar PubMed

[2] Latreille J, Batist G, Laberge F, Champagne P, Croteau D, Falardeau P, et al. Phase I/II trial of the safety and efficacy of AE-941 (neovastat) in the treatment of non-small-cell lung cancer. Clin Lung Cancer. 2003;4(4):231–6.10.3816/CLC.2003.n.003Search in Google Scholar PubMed

[3] Iizuka S, Hayama T, Uchiike A, Tsutsumi D, Yoshida Y. Effects of antacids on clinical efficacy of gefitinib in patients with egfr mutation-positive non-small cell lung cancer. Iryo Yakugaku (Jpn J Pharm Health Care Sci). 2017;43(3):145–53.10.5649/jjphcs.43.145Search in Google Scholar

[4] Nishio M, Taguchi F, Ohyanagi F, Sato Y, Okumura S, Ishikawa Y, et al. Correlation between gefitinib efficacy and her family expression in recurrent non-small-cell lung cancer (nsclc). J Clin Oncol: Off J Am Soc Clin Oncol. 2004;22(14_suppl):3091.10.1200/jco.2004.22.90140.3091Search in Google Scholar

[5] Dammeijer F, Lievense LA, Veerman GD, Hoogsteden HC, Hegmans JP, Arends LR, et al. Efficacy of tumor vaccines and cellular immunotherapies in non-small-cell lung cancer: a systematic review and meta-analysis. J Clin Oncol. 2016;34(26):3204–12.10.1200/JCO.2015.66.3955Search in Google Scholar PubMed

[6] Wakuda K, Kenmotsu H, Naito T, Akamatsu H, Ono A, Shukuya T, et al. Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer. Am J Clin Oncol. 2015;38(1):28–32.10.1097/COC.0b013e318286907bSearch in Google Scholar PubMed

[7] Wang J, Cao L, Xu S. Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: a systematic review and meta-analysis. Int Immunopharmacol. 2020;88(6):106907.10.1016/j.intimp.2020.106907Search in Google Scholar PubMed

[8] Xu X, Li R, Zhu P, Zhang P, Chen J, Lin Y, et al. Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study. World J Surg Oncol. 2021;19(1):231.10.1186/s12957-021-02340-0Search in Google Scholar PubMed PubMed Central

[9] Lu S, Zhang L, Wu YL, Zhang Y, Zhou C, Chen G, et al. An observational study on the efficacy and safety of zoledronic acid (za) in patients with non-small cell lung cancer (nsclc) patients with bone metastases with high urine n-telopeptide (untx) at diagnosis (c-tong 0801). J Clin Oncol: Off J Am Soc Clin Oncol. 2011;29(15_suppl):e19541.10.1200/jco.2011.29.15_suppl.e19541Search in Google Scholar

[10] Kitadai R, Okuma Y, Hakozaki T, Hosomi Y. The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases. J Cancer Res Clin Oncol. 2020;146(17):777–85.10.1007/s00432-019-03104-wSearch in Google Scholar PubMed

[11] Tan DS, Geater S, Yu CJ, Tsai CM, Hsia TC, Chen J, et al. Ceritinib efficacy and safety in treatment-nave asian patients with advanced alk-rearranged non–small cell lung cancer: an ascend-4 subgroup analysis. JTO Clin Res Rep. 2020;2(3):100131.10.1016/j.jtocrr.2020.100131Search in Google Scholar PubMed PubMed Central

[12] Martin C, Lupinacci L, Perazzo F, Bas C, Carranza O, Puparelli C, et al. Efficacy and safety of nivolumab in previously treated patients with non–small-cell lung cancer: Real world experience in argentina. Clin Lung Cancer. 2020;21(5):e380–7.10.1016/j.cllc.2020.02.014Search in Google Scholar PubMed

[13] Hu X, Chen W, Li X, Zhao C, Zhang C, Xiong F, et al. Clinical efficacy analysis of osimertinib treatment for a patient with leptomeningeal metastasis of egfr + non-small cell lung cancer without the t790m mutation. Ann Palliat Med. 2019;8(5):525–31.10.21037/apm.2019.10.13Search in Google Scholar PubMed

[14] Ksienski D, Wai ES, Croteau N, Fiorino L, Brooks E, Poonja Z, et al. Efficacy of nivolumab and pembrolizumab in patients with advanced non–small-cell lung cancer needing treatment interruption because of adverse events: a retrospective multicenter analysis. Clin Lung Cancer. 2019;20(1):97.10.1016/j.cllc.2018.09.005Search in Google Scholar PubMed

[15] Hu X, Lin L, Xing P, Zhang C, Li Y. P2.03a-024 the clinical efficacy and safety of paclitaxel liposome on the patients with non-small cell lung cancer: A meta-analysis. J Thorac Oncol. 2017;12(1):S902.10.1016/j.jtho.2016.11.1233Search in Google Scholar

[16] Tanaka K, Hishinuma S, Mita M, Fukaya Y, Sagawa K, Kanemura T, et al. Effects of antacids on clinical efficacy of gefitinib in patients with non-small cell lung cancer. Iryo Yakugaku. 2010;36(11):832–9.10.5649/jjphcs.36.832Search in Google Scholar

[17] Xiao QM, Zhang WD, Zhou JH. Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bull Hunan Med Univ. 2001;26(4):397–8.Search in Google Scholar

[18] Leduc C, Moussa N, Faivre L, Caramella C, Soria JC, Besse B. Impact of tumor burden on tyrosine kinase inhibitors (tki) efficacy in advanced non-small cell lung cancer (nsclc) patients with egfr-sensitizing mutations (egfrm) and alk rearrangement (alk+). J Clin Oncol. 2014;32(15_suppl):e19021.10.1200/jco.2014.32.15_suppl.e19021Search in Google Scholar

[19] Duarte AC, Costa P, Barroso S. Docetaxel - efficacy of this drug in the second line treatment of non-small-cell lung cancer in a regional oncology unit. J Clin Oncol: Off J Am Soc Clin Oncol. 2004;22(14_suppl):7352–7.10.1200/jco.2004.22.90140.7352Search in Google Scholar

[20] Sirisinha T, Sirilertrakul S, Jirajarus M, Ratanatharathorn V. Doxetaxel in previously treated non-small cell lung cancer patients: clinical efficacy and quality of life. Southeast Asian J Trop Med Public Health. 2005;36(1):246–53.Search in Google Scholar

[21] Gu X, Zhang Y. Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: A retrospective analysis. Ann Palliat Med 10(7):7841–6.10.21037/apm-21-1400Search in Google Scholar PubMed

Received: 2023-05-18
Revised: 2023-07-10
Accepted: 2023-07-27
Published Online: 2023-09-30

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0688/html
Scroll to top button